期刊
JOURNAL OF VIROLOGY
卷 83, 期 21, 页码 11407-11411出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01211-09
关键词
-
类别
资金
- Swedish Research Council
- Swedish International Development Agency
- Swedish Foundation for Strategic Research
- Swedish Physicians Against AIDS Research Foundation
- Swedish National Board of Health and Welfare
- Roche A/S Denmark
- Karolinska Institutet
Chronic immune activation is a driver of human immunodeficiency virus type 1 (HIV-1) disease progression. Here, we describe that subjects with chronic hepatitis C virus (HCV)/HIV-1 coinfection display sharply elevated immune activation as determined by CD38 expression in T cells. This occurs, despite effective antiretroviral therapy, in both CD8 and CD4 T cells and is more pronounced than in the appropriate monoinfected control groups. Interestingly, the suppression of HCV by pegylated alpha interferon and ribavirin treatment reduces activation. High HCV loads and elevated levels of chronic immune activation may contribute to the high rates of viral disease progression observed in HCV/HIV-1-coinfected patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据